With scores of scientists exploring dozens of ideas on how to detect or even cure ovarian cancer, the Rivkin Center is on the cutting edge of ovarian cancer research. We keep a finger on the pulse of research from the world over, and we’ll share it with you here, along with news and insights from our staff, Scientific Board, other experts in the field, and patients and family members affected by ovarian cancer.

The Rivkin Center Awards $1.455M in Ovarian Cancer Research Grants

Seattle, WA: The Rivkin Center, a Seattle-based 501(c)(3), announced that they have awarded $1.455 million in ovarian cancer research grants to sixteen scientists across the globe. The amount funded was nearly a 20% increase over last year. The Rivkin Center’s unique approach to funding provides researchers leverage to access larger pots of federal funds for […]

Meet a CanCan Instructor: Kristin Anderson

The Rivkin Center’s CanCan Program The Rivkin Center for Ovarian Cancer’s CanCan program provides free health education workshops. CanCan instructors educate women about their breast and ovarian health and cancer risks. Say hello to Kristin Anderson, CanCan instructor. ABOUT KRISTIN Where are you from? I grew up in Prior Lake, Minnesota (30 minutes south of […]

Meet a CanCan Ambassador: Elena Santana

The Rivkin Center’s CanCan program provides free health education workshops. CanCan campus ambassadors are the feet-on-the-ground Rivkin Center representatives at universities across the west coast, helping set up workshops, identify opportunities to reach more students, and so much more. Say hello to Elena Santana, a CanCan campus ambassador at the University of Arizona. About Elena […]

FDA Approves Olaparib for Frontline Maintenance Therapy for Ovarian Cancer

ovarian-cancer-in-the-news

The Federal Drug Administration (FDA) made an exciting announcement this week with the first approval for PARP inhibitors to be used for patients following their initial diagnosis and treatment to reduce the risk of recurrence. The FDA approved the use of the PARP inhibitor olaparib (Lynparza®) for frontline maintenance therapy for advanced epithelial ovarian, fallopian […]

CanCan at the University of Washington: Generously sponsored by the Kirwin Hinton Family

The world changed for Bobbie Hinton when her mother, Colleen Kirwin, lost her eight-year battle with ovarian cancer in 2011. Four years later, Bobbie herself was diagnosed with breast cancer. Bobbie and her husband, Dave, are inspired by the work of the Rivkin Center and its fight against two devastating diseases for women: breast cancer […]

Meet a CanCan Instructor and Facilitator: Helen Chen

The Rivkin Center for Ovarian Cancer’s CanCan program provides free health education workshops across the west coast. CanCan facilitators share their cancer journey with CanCan party attendees and help educate women on ovarian and breast health, while CanCan instructors educate women about their breast and ovarian health and cancer risks. Say hello to Helen Chen, CanCan […]

Meet a CanCan Ambassador: Jessica Woods

The Rivkin Center’s CanCan Program The Rivkin Center’s CanCan program provides free health education workshops. CanCan campus ambassadors are the feet-on-the-ground Rivkin Center representatives at universities across the west coast, helping set up workshops, identify opportunities to reach more students, and so much more. Say hello to Jessica Woods, CanCan ambassador at Arizona State University. […]

7 tips for making the most of your annual wellness visit

We get it; your annual wellness exam is an appointment you’re eager to rush through. Even so, it is an important step in prevention and early detection of cancer and a time with your doctor that you should take advantage of. Here are seven tips to ensure you’re advocating for your health — and three […]

Can aspirin prevent ovarian cancer?

ovarian-cancer-in-the-news

You may have read in recent news that a new research study found that daily, low-dose aspirin may lower a woman’s risk of developing ovarian cancer. So does that mean you should start — or change — your aspirin regimen? Dr. Nora Disis, our Medical and Scientific Director and the Director of the University of […]

X